• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. 4 PEG MOD GLEN SZ 2; PROSTHESIS, SHOULDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. 4 PEG MOD GLEN SZ 2; PROSTHESIS, SHOULDER Back to Search Results
Catalog Number SAGL2042
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Bone Fracture(s) (1870); Unspecified Infection (1930); Pain (1994); Osteolysis (2377)
Event Date 03/10/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).Modular post tm cat# sagp0002 lot# 64951711.The device will not be returned for analysis; however, an investigation of the reported event is in progress.Once the investigation is completed, a supplemental medwatch 3500a will be submitted.Multiple mdr reports were filed for this event, please see associated reports: 0001822565 - 2022 - 00925.
 
Event Description
It was reported that a patient underwent a revision procedure approximately 13 months postimplantion due to infection and bone loss.The implants were removed and a cement spacer was placed while a custom implant is being manufactured.Attempts have been made and additional information on the reported event is unavailable at this time.
 
Manufacturer Narrative
This follow-up report is being submitted to relay additional information.Corrected: h6 health effect previously stated 1930- unspecified infection and 1750- erosion.2377-osteolysis, 1994 ¿ pain, and 1870 - bone fracture(s) shall replace both prior codes.
 
Event Description
It was reported that a patient underwent a revision procedure approximately 1 year post implantation due to progressive pain from prior revision.During the revision purulent cloudy fluid was encountered along with scar tissue, pseudocapsule, failure of subscapularis repair, mass with appearance of oyster mushroom, consistent with previous revision findings, osteolysis, loose cement, greater tuberosity periprosthetic fracture, and glenoid vault perforation.All implants removed with antibiotic spacer placed.
 
Event Description
No further event information is available at the time of this report.
 
Manufacturer Narrative
This follow-up report is being submitted to relay additional information.No product was returned or pictures provided; visual and dimensional evaluations could not be performed.Review of the device history record(s) identified no deviations or anomalies during manufacturing related to the reported event.Medical records were provided and reviewed by a health care professional.Review of the available records identified the following: continued to have progressive shoulder pain.Preop diagnosis: failed right anatomic total shoulder arthroplasty, right subscapularis tendon rupture.X-ray; anterior subluxation of humerus consistent with subscapularis tendon failure.General with block.Deltopectoral approach with immediate purulent cloudy fluid and only a thin layer of scar tissue.¿the pectoralis muscle belly was completely scarred to the conjoined tendon, really allowing for no discernible tissue planes in this region.¿ pseudocapsule with purulent cloudy fluid, specimen sent to path.Right subscapularis tendon rupture, fiberwire sutures removed (not a new complaint due to disease progression).Large fungating masses coming out of the shoulder that had the appearance of oyster mushrooms and significant necrosis of soft tissue throughout glenohumeral joint, consistent with findings of with previous revision.Soft tissue excised throughout shoulder and sent to path/ osteolysis of glenoid component, loose cement removed, polyethylene cross hatched and removed in piecemeal fashion, weakening of glenoid vault, and post removed leaving a hole in the glenoid vault perforated which was ¿packed with gelfoam for hemostasis¿.Humeral component removed with slap hammer, greater tuberosity fracture at level of surgical neck related to significant osteolysis.Drain placed, immobilizer sling placed.Infectious disease doctor consulted, iv antibiotic x 6 weeks.Plan a 2nd stage revision for a reverse shoulder.A definitive root cause cannot be determined.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
4 PEG MOD GLEN SZ 2
Type of Device
PROSTHESIS, SHOULDER
Manufacturer (Section D)
ZIMMER BIOMET, INC.
56 e. bell drive
warsaw IN 46582
Manufacturer (Section G)
ZIMMER BIOMET, INC.
56 e. bell drive
warsaw IN 46582
Manufacturer Contact
christina arnt
56 e. bell dr.
warsaw, IN 46582
5745273773
MDR Report Key13999187
MDR Text Key289970867
Report Number0001822565-2022-00924
Device Sequence Number1
Product Code KWS
UDI-Device Identifier00889024644762
UDI-Public(01)00889024644762(17)280804(10)64827338
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K191814
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 07/26/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberSAGL2042
Device Lot Number64827338
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received07/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/21/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SEE H10.
Patient Outcome(s) Hospitalization; Required Intervention;
Patient SexFemale
-
-